Max Healthcare Institute Ltd

As of June 30, 2026, Max Healthcare Institute Ltd carries a market capitalization of 1.10T, placing it among publicly traded companies globally. Its enterprise value stands at 1.10T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Max Healthcare Institute Ltd's next confirmed earnings release is scheduled for October 30, 2026.

As of June 30, 2026, Max Healthcare Institute Ltd has 973.24M shares outstanding.

As of June 30, 2026, Max Healthcare Institute Ltd trades at a trailing price-to-earnings ratio of 75.33.

As of June 30, 2026, Max Healthcare Institute Ltd trades at an EV/EBITDA multiple of 48.42 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 12.62 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 61.19 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.10T versus a market cap of 1.10T, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 3.01M in revenue per employee across its workforce of 28,977.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Max Healthcare Institute Ltd recorded 2.54B in income tax expense. That works out to an effective tax rate of 14.84, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 17.11B, leaving 14.57B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Max Healthcare Institute Ltd's stock has declined approximately 32.56% over the past 52 weeks. The 50-day moving average sits at 969.24, while the 200-day moving average is 1,018.62.

Over the twelve months ended June 30, 2026, Max Healthcare Institute Ltd generated 87.12B in revenue and converted that into 14.57B in net income, yielding earnings per share of 14.91. EBITDA reached 22.70B, while operating income came in at 18.44B.

Over the twelve months ended June 30, 2026, Max Healthcare Institute Ltd posted a gross margin of 78.67, reflecting its pricing power and cost economics. The operating margin of 21.17 and net profit margin of 16.73 provide insight into operational efficiency.